| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Garfield Greg Shaw is a Director at NeuroPace Inc. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $366K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2021 | NPCE Neuropace Inc | Director | Buy | 13,235 | $17.00 | $224,995.00 | +51.7% | -5.8% | -66.5% |